CDBT Stock Overview
China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
China Dasheng Biotechnology Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.014 |
| 52 Week High | US$0.08 |
| 52 Week Low | US$0.0003 |
| Beta | 0 |
| 1 Month Change | -42.62% |
| 3 Month Change | -30.00% |
| 1 Year Change | -57.32% |
| 3 Year Change | -53.33% |
| 5 Year Change | 72.84% |
| Change since IPO | -99.30% |
Recent News & Updates
Recent updates
Shareholder Returns
| CDBT | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 218.2% | -2.9% | -3.7% |
| 1Y | -57.3% | 5.6% | 20.2% |
Return vs Industry: CDBT underperformed the US Chemicals industry which returned 5.4% over the past year.
Return vs Market: CDBT underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| CDBT volatility | |
|---|---|
| CDBT Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CDBT's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine CDBT's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Gang Chen | n/a |
China Dasheng Biotechnology Company, together with its subsidiaries, engages in the production, marketing, and distribution of bacteria based products used as additives for livestock feed and crop cultivation in the People's Republic of China. It provides artificial microorganisms (AM) and high-efficiency microorganism (HM) based biological bacterium blends; and biological preservatives. The company offers AM/HM bacteria based additives for crops, including Bulgaria lactobacillus, beer microzyme, and dark red spirilla used to increase the beneficial microorganism colonies in soil; inhibit the reproduction of harmful fungi and putrefactive bacteria; and to improve nutrient absorption and reduce crop and livestock diseases.
China Dasheng Biotechnology Company Fundamentals Summary
| CDBT fundamental statistics | |
|---|---|
| Market cap | US$573.66k |
| Earnings (TTM) | US$6.41m |
| Revenue (TTM) | US$20.95m |
0.0x
P/E Ratio0.0x
P/S RatioIs CDBT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CDBT income statement (TTM) | |
|---|---|
| Revenue | US$20.95m |
| Cost of Revenue | US$10.93m |
| Gross Profit | US$10.02m |
| Other Expenses | US$3.62m |
| Earnings | US$6.41m |
Last Reported Earnings
Mar 31, 2009
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did CDBT perform over the long term?
See historical performance and comparison